Xencor | BiotechTV

top of page

Feb 2

Five Questions with Xencor CEO Bassil Dahiyat

Bassil Dahiyat walks us through the latest advances in bi-specific antibody engineering and gives his take on L.A.'s biotech scene.

Jun 3, 2023

Company News

Modality profile: Bi-Specifics and cytokines at #ASCO23

Xencor CEO Bassil Dahiyat walks us through the idea behind bi-specific antibodies and cytokines in cancer research.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh